Global  

Trusted News Discovery Since 2008
One News Page
One News Page > In the News > Johnson & Johnson Facts and News Updates

Johnson & Johnson

U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

Johnson & Johnson    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Johnson & Johnson: U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 37 on the 2018 Fortune 500 list of the largest United States corporations by total revenue. J&J is one of the world's most valuable companies.

0
shares
ShareTweetSavePostSend
 

Johnson & Johnson partners with U.S. agency to develop coronavirus vaccine

Johnson & Johnson said on Tuesday it was working with the Biomedical Advanced Research and Development Authority (BARDA) to speed up development of a coronavirus vaccine.
Reuters - Published

Does baby powder cause cancer? A jury ordered Johnson & Johnson to pay $750 million

Is baby powder really safe? The Food and Drug Administration is trying to answer that question about talc, which is similar in structure to asbestos.
USATODAY.com - Published

Videos for Johnson & Johnson


Drugmakers see long road ahead in coronavirus vaccine race [Video]Drugmakers see long road ahead in coronavirus vaccine race

Drugmakers racing to find a vaccine or effective treatment for the deadly new coronavirus in China cautioned that they have a long way to go. Yahaira Jacquez has more.

Credit: Reuters Studio     Duration: 02:13Published

Johnson & Johnson working on vaccine for coronavirus [Video]Johnson & Johnson working on vaccine for coronavirus

As the death toll from the new coronavirus jumped to 132, Johnson & Johnson said it is working on developing a vaccine to stop the outbreak that has infected thousands in China. Colette Luke reports

Credit: Reuters Studio     Duration: 00:53Published

Johnson & Johnson misses revenue estimates [Video]Johnson & Johnson misses revenue estimates

Johnson & Johnson on Wednesday posted a rare miss on quarterly revenue as sales of some of its major drugs fell short of Wall Street expectations. Yahaira Jacquez reports.

Credit: Reuters Studio     Duration: 00:57Published

 

Jury orders Johnson & Johnson to pay $750 million in New Jersey talc case

jury orders johnson & johnson to pay $750 million in new jersey talc case
Johnson & Johnson was ordered on Thursday by a...
WorldNews - Published Also reported by •Reuters

U.S. government experts, industry spar over asbestos testing in talc

For the first time in nearly 50 years, the U.S. Food and Drug Administration examined asbestos testing for talc powders and cosmetics at a hearing on Tuesday, after traces of the known carcinogen were..
Reuters - Published

FDA holds rare public meeting on asbestos testing in talc

For the first time in nearly 50 years, the U.S. Food and Drug Administration examined asbestos testing for talc powders and cosmetics at a hearing on Tuesday, after traces of the known carcinogen were..
Reuters - Published

171 patients received compensation for faulty hip replacements from J&J: Health Ministry


IndiaTimes - Published

J&J CEO questioned over stock sale ahead of story on asbestos in Baby Powder

Johnson & Johnson Chief Executive Alex Gorsky on Monday faced questions from plaintiffs lawyers over the timing of his sale of company stock, as he testified for the first time in a jury trial over..
Reuters - Published

J&J chief testifies he did not read all documents related to asbestos in talc

Johnson & Johnson Chief Executive Alex Gorsky told a jury Monday that he did not read all the internal company documents related to potential asbestos contamination in Johnson's Baby Powder.
Reuters - Published

J&J CEO to testify at trial for first time on Baby Powder risks

Johnson & Johnson Chief Executive Officer Alex Gorsky was set to be called as a witness on Monday in what would be his first appearance in a jury trial over allegations that the company's Baby Powder..
Reuters - Published

J&J forecasts weak annual profit, misses revenue estimates

Johnson & Johnson on Wednesday forecast full-year profit largely below expectations, after posting a rare miss on quarterly revenue as sales of some of its major drugs fell short of Wall Street..
Reuters - Published

J&J misses revenue estimates as blockbuster drugs disappoint

Johnson & Johnson narrowly missed quarterly revenue estimates on Wednesday as sales of its blockbuster psoriasis medicine Stelara and cancer drug Imbruvica fell short of expectations.
Reuters - Published

Johnson & Johnson quarterly profit jumps 32%

Johnson & Johnson on Wednesday posted a 32% rise in fourth-quarter profit, boosted by demand for its cancer drugs Darzalex and Imbruvica.
Reuters - Published

$8 Billion Verdict in Drug Lawsuit Is Reduced to $6.8 Million

A Philadelphia judge lowered the damages in a case that claimed Johnson & Johnson played down the risks of an antipsychotic drug.
NYTimes.com - Published

Judge slashes $8 billion Risperdal award against Johnson & Johnson to $6.8 million

A Pennsylvania judge on Friday slashed to $6.8 million from $8 billion a punitive damages award against Johnson & Johnson to a man who said it failed to warn that boys using its antipsychotic drug..
Reuters - Published

Here's how you can get money from a $6.3 million Infants' Tylenol settlement

Johnson & Johnson agreed to pay $6.3 million to settle a lawsuit over its packaging of Infants' Tylenol.
USATODAY.com - Published

Johnson & Johnson Spent 2019 Dogged by Lawsuits

johnson & johnson spent 2019 dogged by lawsuits
With the year almost over, we’re taking a look at all 30 stocks in the Dow, starting with the worst performer— Walgreens Boots Alliance —and working our way up to the highest-flying stock in the..
WorldNews - Published

Johnson & Johnson says new tests show no asbestos in Johnson's Baby Powder

Johnson & Johnson said on Tuesday that recent tests showed that Johnson's Baby Powder was free of asbestos, after U.S. Food and Drug Administration investigations reported trace amounts of the material..
Reuters - Published

Where were the regulators? How authorities failed pelvic mesh victims

It was a damning judgment against Johnson & Johnson, but also an indictment on the federal agencies that need to protect Australians from harm.
The Age - Published

Johnson & Johnson loses vaginal mesh class action

In one of Australia's biggest class actions, a court ruled the firm failed to warn women of the risks.
BBC News - Published

Johnson & Johnson lose pelvic mesh case to women in landmark judgment

The courtroom was packed with mesh-injured women, representing just a portion of those involved in the class action.
The Age - Published

Whoops. Judge Reduces J&J Opioid Fine After Mistaking Thousands for Millions

Johnson & Johnson will now have to pay $465 million, not $572 million, for its role in Oklahoma’s opioid epidemic.
NYTimes.com - Published

Oklahoma judge reduces Johnson & Johnson opioid payout to $465 million

An Oklahoma judge on Friday said Johnson & Johnson must pay that state $465 million for fueling the opioid epidemic through the deceptive marketing of painkillers, down from his original award of $572..
Reuters - Published

Second Ebola vaccine introduced in the DRC

second ebola vaccine introduced in the drc
Authorities in the Democratic Republic of Congo Thursday introduced a second vaccine to fight the deadly Ebola virus in the east of the country, the Doctors Without Borders (MSF) charity said. It said..
WorldNews - Published

J&J blockbuster loses ground to biosimilars despite Quebec court ruling

Johnson & Johnson's Remicade, a blockbuster drug that treats autoimmune disorders, has steadily lost market share among patients enrolled in the Canadian province of Quebec's public drug program, even..
Reuters - Published

J&J's Remicade losing ground in Quebec health plan despite court victory

Johnson & Johnson's Remicade, a blockbuster drug that treats autoimmune disorders, has steadily lost market share among patients enrolled in the Canadian province of Quebec's public drug program, even..
Reuters - Published

Exclusive: J&J's own expert, working for FDA, found asbestos in Baby Powder

Ever since Johnson & Johnson disclosed this month that a government test had turned up asbestos in its Baby Powder, the company has attacked the validity of the result.
Reuters - Published

J&J says no asbestos in recalled baby power

Company has lost more than 8% of its market value amid concerns about its Baby Powder and the cancer-causing mineral
CBS News - Published

J&J says new tests find no asbestos in same baby powder bottle that sparked recall

Johnson & Johnson said on Tuesday that 15 new tests found no asbestos in a bottle of baby powder that the U.S. Food and Drug Administration says tested positive for trace amounts of asbestos, a finding..
Reuters - Published

Justice Department issues grand jury subpoenas in J&J opioid probe: filing

Johnson & Johnson received grand jury subpoenas in August from the U.S. attorney's office for the Eastern District of New York related to its opioid medication policies, the company said in a..
Reuters - Published

Walgreens, Target remove all 22-ounce J&J baby powder from their shelves

Walgreens Boots Alliance Inc and Target Corp on Friday became the latest retailers to remove all 22-ounce bottles of Johnson & Johnson baby powder from their stores, after the healthcare conglomerate..
Reuters - Published

Big U.S. retailers pull 22-ounce J&J baby powder off shelves after recall

Four major U.S. retailers, including Walmart and Target Corp, are removing all 22-ounce bottles of Johnson & Johnson's baby powder from their stores, following the healthcare conglomerate's recall last..
Reuters - Published

CVS, Rite Aid pull all 22-ounce J&J baby powder from stores

CVS Health Corp and Rite Aid Corp are removing all 22-ounce bottles of Johnson & Johnson's baby powder from their stores, following the healthcare conglomerate's recall last week of some bottles due to..
Reuters - Published

J&J slashes third-quarter profit by $3 billion over proposed opioid deal

Johnson & Johnson on Wednesday lowered its previously reported third-quarter profit by $3 billion to account for a proposed opioid settlement payment.
Reuters - Published

Johnson & Johnson says proposed opioid settlement to lower reported third-quarter profit by $3 billion

Johnson & Johnson on Wednesday lowered its previously reported profit for the third quarter to $1.8 billion from $4.8 billion to account for a proposed opioid settlement payment.
Reuters - Published

You Might Like


 Page 1  〉 
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2020 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.